A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries.
about
Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
P2860
A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A trivalent, inactivated influ ...... ributed in over 120 countries.
@en
A trivalent, inactivated influ ...... ributed in over 120 countries.
@nl
type
label
A trivalent, inactivated influ ...... ributed in over 120 countries.
@en
A trivalent, inactivated influ ...... ributed in over 120 countries.
@nl
prefLabel
A trivalent, inactivated influ ...... ributed in over 120 countries.
@en
A trivalent, inactivated influ ...... ributed in over 120 countries.
@nl
P2093
P2860
P1476
A trivalent, inactivated influ ...... ributed in over 120 countries.
@en
P2093
Anne Woods
Bérengère Macabeo
Margaret Haugh
Sandrine I Samson
Viviane Gresset-Bourgeois
P2860
P304
P356
10.1080/14760584.2017.1324302
P577
2017-05-10T00:00:00Z